Stereotactic Ablative Radiotherapy Clinical Trials
10 recruitingRadiation
Not Applicable4Phase 33Phase 22Phase 11
Showing 1–10 of 10 trials
Recruiting
Phase 2
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more
NRG Oncology240 enrolled318 locationsNCT05327686
Recruiting
Phase 3
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Stage IV Colorectal Cancer AJCC v8Metastatic Colorectal Adenocarcinoma
Alliance for Clinical Trials in Oncology364 enrolled183 locationsNCT05673148
Recruiting
Not Applicable
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Stage III Prostate Cancer AJCC v8Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic144 enrolled5 locationsNCT06325046
Recruiting
Not Applicable
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias
Cardiac Arrhythmia
University Health Network, Toronto60 enrolled1 locationNCT04843683
Recruiting
Phase 3
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Prostate CancerLung CancerColo-rectal Cancer+1 more
Roswell Park Cancer Institute800 enrolled1 locationNCT06563388
Recruiting
Phase 3
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
Metastatic Tumor
David Palma180 enrolled5 locationsNCT05717166
Recruiting
Phase 1
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Solid Tumor
Sichuan University24 enrolled1 locationNCT06349837
Recruiting
Not Applicable
SABR for Renal Tumors
Renal Tumor
University Health Network, Toronto45 enrolled2 locationsNCT03747133
Recruiting
Not Applicable
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
Post Prostatectomy
University Health Network, Toronto100 enrolled1 locationNCT03160794
Recruiting
Phase 2
NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
Renal Cell Carcinoma, Clear Cell, Somatic
Peter MacCallum Cancer Centre, Australia20 enrolled2 locationsNCT05024318